Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.

Nguyen TT, Chakalov BT, Van Noord M, DeCarli C, Hoch JS.

Open source

DOI
10.1002/trc2.70267
Published
2026-04-01
Container
Alzheimers Dement (N Y)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/trc2.70267,
  title = {Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.},
  author = {Nguyen TT and  Chakalov BT and  Van Noord M and  DeCarli C and  Hoch JS.},
  year = {2026},
  journal = {Alzheimers Dement (N Y)},
  doi = {10.1002/trc2.70267},
  url = {https://doi.org/10.1002/trc2.70267}
}

RIS

TY  - JOUR
TI  - Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.
AU  - Nguyen TT
AU  -  Chakalov BT
AU  -  Van Noord M
AU  -  DeCarli C
AU  -  Hoch JS.
PY  - 2026
JO  - Alzheimers Dement (N Y)
DO  - 10.1002/trc2.70267
UR  - https://doi.org/10.1002/trc2.70267
ER  - 

APA

TT, N., BT, C., M, V. N., C, D., & JS., H. (2026). Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.. Alzheimers Dement (N Y). https://doi.org/10.1002/trc2.70267

Source records